PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 7429383

[Essential fatty acids].

F Matzkies
View original source ↗Export metadata ↓

Abstract

Linoleic acid, gamma-linoleic acid and arachidonic acid are essential substrates for human nutrition. The daily requirement of linoleic acid or linoleic acid equivalent are 6.5 g/die. The recommended dietary allowance (RDA) for safety intake has been fixed to 10 g/die. During deficiency of essential fatty acids (EFA) linoleic acid concentration in tissue is diminished and the prostaglandin synthesis is lowered, too. Prostaglandins are formed exclusively from linoleic acid equivalent, mostly arachidonic acid. Augmented application of EFA lowers cholesterol and triglicerides concentration in blood. An antihypertensive effect of EFA has recently been described. Unsaturated fatty acids can be used in therapy of hypercoagulability. In the dietary treatment of diabetes mellitus EFA improve the effect of insulin. EFA stop the development of atheromatosis. Therefore one should not hesitate to practice an EFA-rich diet.

Explore related subjects

Arachidonic AcidsArteriosclerosisDiabetes MellitusDietary FatsFatty Acids, EssentialFatty LiverHumansHypertensionLinoleic AcidsLinolenic AcidsNutritional Physiological PhenomenaNutritional RequirementsOleic AcidsPalmitic AcidsProstaglandinsEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F Matzkies. 1980-06-26. [Essential fatty acids].. https://pubmed.ncbi.nlm.nih.gov/7429383/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1997

Todd's achievement.

Explore the source record for details and available documents.

Arachidonic Acids↗
PubMed1997

Depletion of human monocyte 85-kDa phospholipase A2 does not alter leukotriene formation.

Human monocytes possess several acylhydrolase activities and are capable of producing both prostanoids (PG) and leukotriene (LT) products upon acute stimulation with calcium ionophore, A23187 or phagocytosis of zymosan particles. The cytosolic 85-kDa phospholipase (PLA) A2 co-exists with the 14-kDa PLA2 in the human monocyte, but their respective roles in LT production are not well understood. Reduction in 85-kDa PLA2 cellular protein levels by initiation site-directed antisense (SK 7111) or exposure to the 85-kDa PLA2 inhibitor, arachidonyl trifluoromethyl ketone (AACOCF3), prevented A23187 or zymosan-stimulated monocyte prostanoid formation. In contrast, neither treatment altered stimulated LTC4 production. This confirmed the important role of the 85-kDa PLA2 in prostanoid formation but suggests that it has less of a role in LT biosynthesis. Alternatively, treatment of monocytes with the selective, active site-directed 14-kDa PLA2 inhibitor, SB 203347, prior to stimulation had no effect on prostanoid formation at concentrations that totally inhibited LT formation. Addition of 20 microM exogenous arachidonic acid to monocytes exposed to SK 7111 or SB 203347 did not alter A23187-induced PGE2 or LTC4 generation, respectively, indicating that these agents had no effect on downstream arachidonic acid-metabolizing enzymes in this setting. Taken together, these results provide evidence that the 85-kDa PLA2 may play a more significant role in the formation of PG than LT. Further, utilization of SB 203347 provides intriguing data to form the hypothesis that a non-85-kDa PLA2 sn-2 acyl hydrolase, possibly the 14-kDa PLA2, may provide substrate for LT formation.

Arachidonic Acids↗
PubMed1997

Antithrombotic action of the kava pyrone (+)-kavain prepared from Piper methysticum on human platelets.

(+)-Kavain, a 4-methoxy-alpha-pyrone prepared from Piper methysticum Forst. (Piperaceae), was investigated regarding its assumed antithrombotic action on human platelets which was deduced from its ability to suppress arachidonic acid (AA)-induced aggregation, exocytosis of ATP, and inhibition of cyclooxygenase (COX) and thromboxane synthase (TXS) activity, the latter two effects being estimated from the generation of prostaglandin E2 (PGE2) and thromboxane A2 (TXA2), respectively. Exogenously applied AA (100 mumol/l) provoked a 90% aggregation of platelets, the release of 14 pmol ATP, and the formation of either 220 pg TXA2 or 43 pg PGE2, each parameter being related to 10(6) platelets. An application of (+)-kavain 5 min before AA, dose-dependently diminished aggregation, ATP-release, and the synthesis of TXA2 and PGE2 with IC50 values of 78, 115, 71, and 86 mumol/l, respectively. The similarity of the IC50 values suggest an inhibition of COX by (+)-kavain as primary target, thus suppressing the generation of TXA2 which induces aggregation of platelets and exocytosis of ATP by its binding on TXA2-receptors.

Arachidonic Acids↗